Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
The American Surgeon|April 16, 2021
Minimally Invasive Mastectomy Could Achieve Non-inferior Oncological Outcome in Appropriately Selected Patients: Propensity Matched Analysis of the National Cancer DatabaseLifen Cao, Robert Shenk, Megan E Miller, et al.Cancer Medicine|September 28, 2023
Estimating the overall survival benefit of adjuvant chemo-endocrine therapy in women over age 50 with pT1-2N0 early stage breast cancer and 21-gene recurrence score ≥26: A National Cancer Database analysisNickolas Stabellini, Lifen Cao, Christopher W Towe, et al.American Journal of Surgery|October 8, 2022
Trends in surgery and survival for T1-T2 male breast cancer: A study from the National Cancer DatabaseRashi Singh, Lifen Cao, Anuja L Sarode, et al.The Journal of Surgical Research|January 19, 2023
Adjuvant Therapy in Breast Cancer Patients With Microscopic Residual DiseaseLifen Cao, Robert Shenk, Nickolas Stabellini, et al.Cancer|April 1, 2022
A comparison of local therapy alone with local plus systemic therapy for stage I pT1aN0M0 HER2+ breast cancer: A National Cancer Database analysisLifen Cao, Christopher W Towe, Robert Shenk, et al.Frontiers in Oncology|May 11, 2023
Adjuvant chemotherapy is associated with an overall survival benefit regardless of age in ER+/HER2- breast cancer pts with 1-3 positive nodes and oncotype DX recurrence score 20 to 25: an NCDB analysisNickolas Stabellini, Lifen Cao, Christopher W Towe, et al.Breast Cancer Research and Treatment|October 16, 2021
Adjuvant trastuzumab with or without chemotherapy in stage 1 pT1N0 HER2+ breast cancer: a National Cancer Database analysisLifen Cao, Robert Shenk, Nickolas Stabellini, et al.Scientific Reports|January 22, 2023
Racial disparities in breast cancer treatment patterns and treatment related adverse eventsNickolas Stabellini, Jennifer Cullen, Lifen Cao, et al.Annals of Surgical Oncology|April 7, 2021
Despite Equivalent Outcomes, Men Receive Neoadjuvant Chemotherapy Less Often Than Women for Lymph Node-Positive Breast CancerLifen Cao, Jonathan J Hue, Mary Freyvogel, et al.Journal of the National Comprehensive Cancer Network : JNCCN|October 19, 2023
Validation of the PREDICT Prognostication Tool in US Patients With Breast CancerNickolas Stabellini, Lifen Cao, Christopher W Towe, et al.Pageof 2